David Attwood
Finanzdirektor/CFO bei THCinol/CBDinol CanPharma GmbH
Aktive Positionen von David Attwood
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
THCinol/CBDinol CanPharma GmbH
THCinol/CBDinol CanPharma GmbH Pharmaceuticals: OtherHealth Technology Part of CanPharma GmbH /Jacker/, THCinol/CBDinol CanPharma GmbH is a German company that brings years of experience in the treatment with cannabinoids and necessary expertise to ensure a professional handling of medical cannabis. The company is based in Oranienburg, Germany. The company aims to fully unleash the potential of medical cannabis with a focus on the well-being of the patient. The company offers quality products, specialized information, and a CanPharma patient ID. The company was founded by Holger Sprengel and Henrik Arne Sprengel, with Henrik Arne Sprengel serving as CEO since incorporation. THCinol/CBDinol CanPharma was acquired by CanPharma GmbH /Jacker/ from Health House International Ltd. on November 16, 2022. | Finanzdirektor/CFO | - | - |
Karriereverlauf von David Attwood
Ehemalige bekannte Positionen von David Attwood
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HEALTH HOUSE INTERNATIONAL | Vorstandsvorsitzender | 10.08.2021 | 19.03.2023 |
Ausbildung von David Attwood
The University of Nottingham | Graduate Degree |
Instituto de Estudios Superiores de la Empresa | Masters Business Admin |
Statistik
International
Deutschland | 2 |
Vereinigtes Königreich | 2 |
Spanien | 2 |
Operativ
Director of Finance/CFO | 1 |
Graduate Degree | 1 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
THCinol/CBDinol CanPharma GmbH
THCinol/CBDinol CanPharma GmbH Pharmaceuticals: OtherHealth Technology Part of CanPharma GmbH /Jacker/, THCinol/CBDinol CanPharma GmbH is a German company that brings years of experience in the treatment with cannabinoids and necessary expertise to ensure a professional handling of medical cannabis. The company is based in Oranienburg, Germany. The company aims to fully unleash the potential of medical cannabis with a focus on the well-being of the patient. The company offers quality products, specialized information, and a CanPharma patient ID. The company was founded by Holger Sprengel and Henrik Arne Sprengel, with Henrik Arne Sprengel serving as CEO since incorporation. THCinol/CBDinol CanPharma was acquired by CanPharma GmbH /Jacker/ from Health House International Ltd. on November 16, 2022. | Health Technology |
Health House International Ltd.
Health House International Ltd. Pharmaceuticals: OtherHealth Technology Health House International Ltd. engages in the distribution of medicinal cannabis. The company was founded by Jason Peterson and Harry Karelis in 2014 and is headquartered in Melbourne, Australia. | Health Technology |
- Börse
- Insiders
- David Attwood
- Erfahrung